Training & Education

Type 1 Diabetes Fellows Series

April 19, 2022

The Application Deadline is closed for the ninth annual installment of our Type 1 Diabetes Fellows series. At the heart of this program is a desire to address skill and workforce gaps by providing comprehensive education on type 1 diabetes care while also strengthening the network of next generation endocrinologists.

This year we updated the Type 1 Diabetes Fellows Conference format to incorporate the best parts from both the pre-pandemic program and our online program from last year. This year’s program had two core components:

30-minute on-demand microlearning sessions; and
a prestigious, in-person meeting held in Atlanta June 9-10, ahead of ENDO, where fellows get the exclusive opportunity to meet with experts in T1D and product demonstrations with industry representatives.

In-person Meeting Schedule:

Fellows that are invited to attend the in-person meeting will be provided with both travel and lodging.

Early Spring 2022	On-Demand Microlearning sessions launch
June 9, 2022	Welcome Reception Dinner Keynote Address with Q&A Product Showcase
June 10, 2022	Lectures Small group and lunch discussions with faculty Breakout sessions

On Demand Program (30-min sessions)

Diagnosing and Understanding Risks of T1D

Challenging Cases in the Diagnosis of T1D

Irl B. Hirsch, MD, University of Washington

Hypoglycemia in T1D: Risks and Practical Prevention Strategies

Elizabeth Seaquist, MD, University of Minnesota

Phases of diabetes

Carla J. Greenbaum, MD, Benaroya Research Institute

Screening, Preventing, and Treating Vascular Disease

T1D and the Prevention and Treatment of Macrovascular Disease

Robert H. Eckel, MD, University of Colorado

The Endocrinologist’s Role in Screening/Managing Microvascular Disease

Janet McGill, MD, MA, FACE, Washington University in St. Louis

Addressing Depression in T1D and Challenges across the Lifespan

Identifying and Confronting Challenging Transitions

Linda Siminerio, PhD, University of Pittsburgh

Developmental Perspectives in the Psychosocial Aspects of Diabetes

Jill A. Weissberg-Benchell, PhD, CDE, Northwestern University

Nutrition and Exercise in T1D Management

Implementing Realistic Nutrition Strategies

Alison B. Evert, MS, RD, CDE, University of Washington

Exercise Management: Considerations and Strategies for T1D

Michael C. Riddell, PhD, York University

Diabetes, Pregnancy & Breastfeeding

Camille Powe, MD, Massachusetts General Hospital

The Pathogenesis of T1D: The Future for Preserving Beta Cell Function

Mark Atkinson, PhD, University of Florida

How to Effectively Bill for a Diabetes Visit

Carol Wysham, MD, Rockwood Clinic PS (Endocrine Society President)

Thursday, June 9, 2022

6:00–6:30 PM	Welcome Reception
6:30–7:00 PM	Dinner
7:00–7:45 PM	Keynote Address: Navigating T1D and the Elite Athlete Anne Peters, MD, USC Westside Center for Diabetes
7:45–8:00 PM	Q&A
8:00 – 9:30 PM	Product Showcase

Friday, June 10, 2022

7:00–8:00 AM	Registration and Breakfast with the Faculty
8:00–8:10 AM	Welcoming Remarks Irl B. Hirsch, MD, University of Washington Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health System
8:10–8:50 AM	Closing the Loop with Diabetes Technology Practical Considerations and Approaches to Data Management Grazia Aleppo, MD, Northwestern University, Feinberg School of Medicine
8:50–9:30 AM	Closing the Loop with Diabetes Technology Insights into Insulin Pump Therapy Jessica Castle, MD, Oregon Health & Science University
9:30–10:10 AM	Closing the Loop with Diabetes Technology Interpreting CGM with Your Patients Rich Bergenstal, MD, International Diabetes Center
10:10–10:40 AM	Break & Questions for Industry Representatives
10:40–11:10 AM	Small Group Discussion: Closing the Loop with Diabetes Technology (Discussions on day-to-day management using CGM) Practical Considerations and Approaches to Data Management Grazia Aleppo, MD, Northwestern University, Feinberg School of Medicine Insights into Insulin Pump Therapy Jessica Castle, MD, Ohio State University Interpreting CGM with Your Patients Rich Bergenstal, MD, International Diabetes Center Setting Up Technology in Practice on Your Own Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health System
11:10–11:50 AM	Interpreting Study Findings: Moving toward a Better Understanding of Today’s Literature Roy W. Beck, MD, PhD, Jaeb Center for Health Research
11:50AM–12:30 PM	Preparing for Future Careers in Endocrinology: What I Wish I was Told When I Left my Fellowship Luisa Duran, MD, John Muir Health
12:30–1:30 PM	Lunch Discussion with Faculty: During lunch, we encourage fellows to join faculty at specified tables to discuss specific topics: How to Effectively Bill for A Diabetes Visit – Luisa Duran, MD, John Muir Health Insulin Cases – Lucia Novak, MSN, ANP-BC. BC-ADM, Capital Diabetes & Endocrine Associates T1D and Mental Health – Grazia Aleppo, MD, Northwestern University, Feinberg School of Medicine Practical Considerations for Preparing Your Patient for the Hospital – Anne Peters, MD, USC Westside Center for Diabetes Exciting Happenings in T1D in the Next 5 Years – Irl B. Hirsch, MD, University of Washington
1:30–2:10 PM	Principles in Insulin and Emerging Non-Insulin Therapies A Fresh Look at Insulin Therapy Irl B. Hirsch, MD, University of Washington
2:10–2:50 PM	Principles in Insulin and Emerging Non-Insulin Therapies Breakout Sessions Optimizing Multiple Daily Injection Therapy Lucia Novak, MSN, ANP-BC. BC-ADM, Capital Diabetes & Endocrine Associates Going Beyond Insulin: Updates on Non-Insulin Options for T1D Anne Peters, MD, USC Westside Center for Diabetes
2:50–3:30 PM	Principles in Insulin and Emerging Non-Insulin Therapies Breakout Sessions Repeat
3:30–3:40 PM	Break
3:40–4:20 PM	Caring for the Sick Patient at Home Jennifer Sherr, MD, PhD, Yale School of Medicine
4:20–5:20 PM	Small Group Discussion: Nutrition – Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health System T1D in Underserved Populations – Anne Peters, MD, USC Westside Center for Diabetes Topic TBD – Rich Bergenstal, MD, International Diabetes Center Dealing with Families of Newly Diagnosed T1D Patients – Jennifer Sherr, MD, PhD, Yale School of Medicine
5:20–5:30 PM	Closing Comments Irl B. Hirsch, MD, University of Washington Davida F. Kruger, MSN, APN-BC, BC-ADM, Henry Ford Health System

2022 Learning Objectives
Upon successful completion these educational initiatives, participants should be better able to:

Discuss the prevalence and progression of type 1 diabetes to recognize signs and differentially diagnose diabetes.
Devise individualized treatment strategies that use new and emerging insulin and non-insulin therapies to manage individuals with type 1 diabetes with and without common comorbid conditions.
Incorporate diabetes technologies, including insulin pump therapy and continuous glucose monitoring, into treatment strategies for appropriate individuals with type 1 diabetes and evaluate data from those technologies.
Recognize and evaluate individuals with type 1 diabetes for signs of depression and distress using updated guidelines and practice tools.
Apply updated knowledge of treatments, practice guidelines, and clinical skills to improve care, long-term outcomes, and sick day management of individuals with type 1 diabetes.

Last Updated: April 19, 2022